Showing results (61-70 of 551) with videos related to
Sort By:
Pageof 56
Annual Review of Pharmacology and Toxicology|October 15, 2008
Immunodrugs: therapeutic VLP-based vaccines for chronic diseasesGary T Jennings, Martin F BachmannCurrent Opinion in Immunology|March 27, 2010
Vaccines against non-communicable diseasesTill A Röhn, Martin F BachmannHuman Vaccines & Immunotherapeutics|August 28, 2013
Plasmodium vivax malaria vaccines: why are we where we are?Arturo Reyes-Sandoval, Martin F BachmannThrombosis Research|October 15, 1982
Influence of detergents on the measurement of the fibrinolytic activity of plasminogen activatorsE K Kruithof, A Ransijn, F BachmannCancer Research|March 1, 1997
Cloning of a novel protein overexpressed in human mammary carcinomaF Bachmann, R Bänziger, M M BurgerJournal of Immunology (Baltimore, Md. : 1950)|April 7, 2010
Cutting edge: IL-21 and TLR signaling regulate germinal center responses in a B cell-intrinsic mannerJuliana Bessa, Manfred Kopf, Martin F BachmannSchweizerische Medizinische Wochenschrift|December 7, 1985
[Willebrand's disease and multimeric analysis of the Willebrand factor]J Hauert, C Tran-Thang, F BachmannSchweizerische Medizinische Wochenschrift|February 18, 1989
[Acute monoblastic leukemia complicated by fatal splenic rupture following initiation of chemotherapy]A Borgeat, C Tran-Thang, F BachmannBlood|November 1, 1987
Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregationE K Kruithof, G Nicolosa, F BachmannEuropean Journal of Immunology|August 15, 2000
The antigen dose determines T helper subset development by regulation of CD40 ligandC Ruedl, M F Bachmann, M KopfPageof 56